title: Patent eligibility of stem cells in Europe: where do we stand after 8 years of case law?
abstract: Since 2006, some of the highest ranking European Courts have issued decisions related to the patent eligibility of human embryonic stem cells. The question of patent eligibility of human embryonic stem cells remains, however, still erratic, at least in some aspects. This article will give a short comprehensive overview of the case history, and discuss questions still unsolved.
authors.affiliation: Michalski ⋅ Hüttermann & Partner Patent Attorneys, Düsseldorf, Germany.
authors.forename: Ulrich
authors.initials: U
authors.lastname: Storz
authors.affiliation: Martin Luther University, Halle-Wittenberg, Germany, Faculty of Law, Economics and Business.
authors.forename: Timo
authors.initials: T
authors.lastname: Faltus
mesh_terms: D005062:European Union; D000066449:Human Embryonic Stem Cells / Q000166:cytology*; D006801:Humans; D018973:Intellectual Property; D010330:Patents as Topic / Q000941:ethics* / Q000331:legislation & jurisprudence*; D057905:Stem Cell Research / Q000941:ethics* / Q000331:legislation & jurisprudence*
keywords: Brüstle; EPO; biopatent directive; embryo; non-destructive parthenotes; patent; stem cells